SMR Bounces Hard While Peers Diverge Sharply

SMR enters the week carrying real momentum, up 6.7% over the past five sessions and 2.8% on Thursday alone, yet that rally sits against a backdrop of sharply divergent peer performance and a fresh earnings scar that is still raw in market memory.

The most striking feature of this week's setup is the earnings hangover. Just over two weeks ago, Stanmore fell 15.8% on the day of its results and extended those losses to 18.9% over the following five sessions — a brutal reaction by any measure. Thursday's bounce takes the stock back to AUD 2.56, but that still leaves it well below the pre-result level. Two analysts maintain buy ratings with a mean price target near AUD 3.23, implying roughly 26% upside from current levels — though that consensus has not been refreshed since late July and should be treated with some caution given how much the stock has moved in the intervening weeks. One hold rating sits alongside the two buys. Valuation reads cheap on a P/B of 0.98 and an EV/EBITDA of 3.9x, with the EV/EBITDA expanding modestly over the past month as the stock has stabilised. EPS momentum factor scores remain a bright spot — ranking in the 90th and 91st percentiles on the 30-day and 90-day measures — suggesting analysts had been lifting forward estimates even before the market reacted so harshly to the result itself.

The lending market tells a story of almost complete indifference from short sellers. Borrow availability is essentially uncapped — the pool of lendable shares is so large relative to demand that it reads at its theoretical maximum — and the cost to borrow has more than halved over the past week, falling to 0.83% from around 1.56%. Short interest itself edged up 0.5% on the day but is down 9.3% on the week, and the ORTEX short score of 27 ranks in a comfortable position relative to the broader universe, implying no material short-side pressure. This is consistent with a stock where the dominant shareholder — Singapore-based Star Success Pte Ltd — controls 59% of the register, leaving a relatively thin free float for anyone attempting to build a significant short position.

Ownership is the structural story worth watching on SMR. With Star Success holding nearly three-fifths of the company and Matthew Latimore sitting on a further 4.8%, the free float is genuinely small. Among active institutional holders, Regal Partners trimmed its position by around 8.2 million shares as of February, while Orbis Investment Management added 27.7 million shares in the same period — a meaningful accumulation for a contrarian value house. Dimensional and State Street each added modestly in the June quarter. BlackRock's most recent update through July 31 shows a largely flat position. The net effect is a register that is broadly stable at the institutional level, with no single institution making a dramatic exit.

Peer performance adds a complicating layer. CRN fell 3.1% on Thursday and is down 11.4% on the week, suggesting the thermal coal complex is not uniformly recovering. PVT also dropped 3.1% on the day, though it is up 6.9% on the week. The Hong Kong-listed peers — including names correlated in the high-30s to low-40s percentage range — delivered more mixed results, with one gaining 20.8% on the week and another slipping. SMR's 6.7% weekly move therefore looks decent in context, though it is more recovery-from-shock than sector-led rerating.

The dividend history adds one more data point worth noting. The February 2026 payout of AUD 0.125 per share translates to a yield of around 4.9% on the current price — a meaningful income component for holders prepared to sit through the coking coal cycle, with the DPS/Price factor still running near 6.4%.

With the immediate post-earnings period absorbed and short sellers pulling back rather than adding, the next meaningful signal will come from any update on coking coal pricing and whether the August half-year result — which appears to have already been released given the August 13 earnings date in the history — prompts any formal analyst revisions that shift the consensus off its current buy-leaning stance.